Cheryl A. Moore

Cheryl Moore joined Wellcome in May 2021, taking on the new role of Director of Research Programmes. As Wellcome evolves to deliver its new strategy, Cheryl is leading a broad interlinked portfolio that focuses on discovery research and three challenge-led research programmes: mental health, infectious diseases, and climate and health.

Before joining Wellcome, Cheryl was President and Chief Operating Officer of the New York Genome Center. Prior to this, she served as Executive Vice President and Chief Operating Officer of the Howard Hughes Medical Institute (HHMI) in the US. She was also the founding Chief Operating Officer of HHMI’s Janelia Research Campus, an innovation hub in Virginia.

She is currently a member of the Genome Research Limited Board of Directors, the parent company of the Wellcome Sanger Institute and Wellcome Genome Campus.